Injectable bone morphogenetic protein
AssigneeWarsaw Orthopedic, Inc.
InventorPing Li
Life of this patent
Estimating the term…
Abstract
A method of treating a bone defect is provided. The method comprises administering to the bone defect an injectable solution comprising about 20 μg to about 5000 μg of bone morphogenetic protein-2 (BMP-2) in an aqueous carrier. Kits and methods of making are also provided.
Claims20
A method of treating a bone defect, the method comprising administering to the bone defect an injectable solution comprising about 20 μg to about 5000 82 g of bone morphogenetic protein-2 (BMP-2) in an aqueous carrier.
A method of making an injectable bone morphogenetic protein-2 solution, the method comprising mixing about 20 μg to about 5000 μg of lyophilized bone morphogenetic protein-2 (BMP-2) with an aqueous carrier to form the injectable bone morphogenetic protein-2 solution.
A kit for treating a bone defect, the kit comprising a 20 μg to about 5000 μg dosage of injectable bone morphogenetic protein-2 (BMP-2);
- an aqueous carrier to mix the injectable BMP-2;
- and a set of instructions for administering the injectable BMP-2.
Dependencies are inferred from the claim text.